
|Articles|June 1, 2011
- Pharmaceutical Executive-06-01-2011
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - June 2011
Emerging Pharma Leaders 2011
Advertisement
Articles in this issue
almost 15 years ago
Educating Physiciansalmost 15 years ago
To Genzyme, Quality Data Depends on Quality Governancealmost 15 years ago
Drugstore Vaccinationsalmost 15 years ago
A Lack of Informationalmost 15 years ago
Getting IT Togetheralmost 15 years ago
The Futuristic Insightalmost 15 years ago
Optimizing your Value with Payersalmost 15 years ago
Managing Product Lifecyclealmost 15 years ago
To Screen or Not to Screen?almost 15 years ago
Start Serious, Become BolderAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly’s Foundayo and Lower-Dose Zepbound Helped Maintain Weight Loss in Patients Switching from Injectables
2
Pharmaceutical Executive Daily: Rigel Pharmaceuticals Enters an Exclusive Global Licensing Agreement with Arvinas and Pfizer for Veppanu
3
Beyond the Molecule: The New Competitive Battlefield in Oncology
4
FDA Approves Beqalzi for Relapsed or Refractory Mantle Cell Lymphoma, Inqovi in Combination with Venetoclax
5




